Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

Clinical trial NCT00281879 · TERMINATED

Trial details

NCT number: NCT00281879
Sponsor: OHSU Knight Cancer Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Unusual Cancers of Childhood

Start date: 2006-02-01
Primary completion: 2008-02-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.